@article{ddd06833a52b42b190e6a0d2e069fca9,
title = "Induction Immunosuppressive Therapy for Kidney Transplant in Elderly Recipients: A Single-Center Experience",
author = "El-Hag, \{Amanda D\} and Ann Dao and Allam, \{Sridhar R\} and Guiteau, \{Jacfranz J\} and Madhrira, \{Machaiah M\} and Reyad, \{Ashraf I\}",
note = "Objectives The number of elderly kidney transplant recipients is increasing, and age-tailored induction immunosuppression regimens are needed. We compared safety and efficacy of basiliximab versus thymoglobulin at various dosages. Materials and methods Of 590 kidney transplants at our center from 2012 to 2019, 119 (20.1\%) were for recipients over 65 years of age; 118 patients received deceased donor kidneys, and 1 received a related living donor kidney.",
year = "2021",
month = apr,
day = "1",
doi = "10.6002/ECT.2020.0434",
language = "American English",
volume = "19",
journal = "Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation",
issn = "2146-8427",
number = "4",
}